AstraZeneca Pharma India Limited (ASTRAZEN)

7,733.25

INR
-74.10(-0.95%)
As of March 12, 2025 9:20:00 AM

About AstraZeneca Pharma India Limited

AstraZeneca Pharma India Ltd., a significant entity in the pharmaceutical sector, concentrates on manufacturing and marketing a comprehensive range of medicinal products. As a subsidiary of the global biopharmaceutical giant AstraZeneca, this company plays a pivotal role in the Indian market, providing medications across diverse therapeutic areas such as oncology, cardiovascular, renal, and metabolic diseases. AstraZeneca Pharma India Ltd. is renowned for its research-driven approach, emphasizing the development of innovative treatments that address unmet medical needs. By integrating its expertise in global pharmaceutical advancements with local health requirements, AstraZeneca Pharma India Ltd. contributes to the improvement of public health infrastructure and patient care in India, underscoring its importance in the nation's healthcare landscape.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
12.06
Operating MarginLast 12 months
15.43
+95.19999999999999% quarterly YoY
Market Cap
19518.38 CrINR
Employees
940
CEO
NA
Website